"What's So Bloody Funny?" annual Halloween fundraiser helps NHF raise funds and spirits with a night of comedy in NYC.
BPL’s new therapy offers better treatment for people with FX deficiency.
Board sec'y of Hemophilia Foundation of Minnesota/Dakotas is pleasantly surprised by NHF's 67th Annual Meeting in Dallas.
Take the B-HERO-S survey and contribute to a better understanding of the psychosocial issues of living with hemophilia B.
FDA approves Octapharma’s latest therapy NUWIQ®, for people with hemophilia A. Clinical trial data showed good to excellent results overall.
BioMarin announces enrollment of the first patient in clinical trial of BMN 270, a gene therapy to treat people with hemophilia A.
January 22 is the deadline to submit research poster abstracts for the WFH 2016 World Congress in Orlando, Florida, July 24-28, 2016.
Last night on the Tonight Show Lady Gaga linked hemophilia to her vampire TV character.
The goal of this activity is to discuss the unique challenges facing nurses who treat adults with hemophilia.
NHF and IMPACT announce the CCSC, an ongoing quality improvement and cost-management initiative driven by HTC and payer/managed care professionals.
eNewsletter Sign Up
Steps for Living
Victory for Women
Donate Your Car